These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 36960964)
1. Long Noncoding RNA H19: A Novel Oncogene in Liver Cancer. Wang Y; Zeng J; Chen W; Fan J; Hylemon PB; Zhou H Noncoding RNA; 2023 Mar; 9(2):. PubMed ID: 36960964 [TBL] [Abstract][Full Text] [Related]
2. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1. Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA H19: functions and mechanisms in regulating programmed cell death in cancer. Xia Y; Pei T; Zhao J; Wang Z; Shen Y; Yang Y; Liang J Cell Death Discov; 2024 Feb; 10(1):76. PubMed ID: 38355574 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis. Nokkeaw A; Thamjamrassri P; Chantaravisoot N; Tangkijvanich P; Ariyachet C Oncol Res; 2023; 31(6):989-1005. PubMed ID: 37744274 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition. Xu Y; Wang Z; Jiang X; Cui Y Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells. Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678 [TBL] [Abstract][Full Text] [Related]
7. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis. Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662 [TBL] [Abstract][Full Text] [Related]
8. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma. Ye Y; Guo J; Xiao P; Ning J; Zhang R; Liu P; Yu W; Xu L; Zhao Y; Yu J Cancer Lett; 2020 Jan; 469():310-322. PubMed ID: 31705929 [TBL] [Abstract][Full Text] [Related]
9. Targeting long non-coding RNA H19 as a therapeutic strategy for liver disease. Shi Y; Qu F; Zeng S; Wang X; Liu Y; Zhang Q; Yuan D; Yuan C Prog Biophys Mol Biol; 2024 Dec; 194():1-9. PubMed ID: 39357625 [TBL] [Abstract][Full Text] [Related]
10. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner. Wang WT; Ye H; Wei PP; Han BW; He B; Chen ZH; Chen YQ J Hematol Oncol; 2016 Nov; 9(1):117. PubMed ID: 27809873 [TBL] [Abstract][Full Text] [Related]
11. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis. Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H Transl Res; 2020 Oct; 224():26-39. PubMed ID: 32505707 [TBL] [Abstract][Full Text] [Related]
12. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA. Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971 [TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR‑675. Xu Y; Liu Y; Li Z; Li H; Li X; Yan L; Mao J; Shen J; Chen W; Xue F Oncol Rep; 2020 Jul; 44(1):165-173. PubMed ID: 32627034 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Zhang L; Yang F; Yuan JH; Yuan SX; Zhou WP; Huo XS; Xu D; Bi HS; Wang F; Sun SH Carcinogenesis; 2013 Mar; 34(3):577-86. PubMed ID: 23222811 [TBL] [Abstract][Full Text] [Related]
15. Aberrant NSUN2-mediated m Sun Z; Xue S; Zhang M; Xu H; Hu X; Chen S; Liu Y; Guo M; Cui H Oncogene; 2020 Nov; 39(45):6906-6919. PubMed ID: 32978516 [TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia. Xiao Y; Liu R; Li X; Gurley EC; Hylemon PB; Lu Y; Zhou H; Cai W Hepatology; 2019 Nov; 70(5):1658-1673. PubMed ID: 31063660 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA H19 - a new player in the pathogenesis of liver diseases. Yang Z; Zhang T; Han S; Kusumanchi P; Huda N; Jiang Y; Liangpunsakul S Transl Res; 2021 Apr; 230():139-150. PubMed ID: 33227504 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Hashemi M; Moosavi MS; Abed HM; Dehghani M; Aalipour M; Heydari EA; Behroozaghdam M; Entezari M; Salimimoghadam S; Gunduz ES; Taheriazam A; Mirzaei S; Samarghandian S Pharmacol Res; 2022 Oct; 184():106418. PubMed ID: 36038043 [TBL] [Abstract][Full Text] [Related]
19. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma. Song Y; Xing H; Zhou L; Zhang N; Yang M Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499 [TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]